| Head-to-head comparison of transrectal ultrasound-guided prostate biopsy versus multiparametric prostate resonance imaging with subsequent magnetic resonance-guided biopsy in … M van der Leest, E Cornel, B Israel, R Hendriks, AR Padhani, ... European urology 75 (4), 570-578, 2019 | 701 | 2019 |
| ESUR/ESUI consensus statements on multi-parametric MRI for the detection of clinically significant prostate cancer: quality requirements for image acquisition, interpretation … M de Rooij, B Israël, M Tummers, HU Ahmed, T Barrett, F Giganti, ... European radiology 30, 5404-5416, 2020 | 206 | 2020 |
| High diagnostic performance of short magnetic resonance imaging protocols for prostate cancer detection in biopsy-naïve men: the next step in magnetic resonance imaging … M van der Leest, B Israel, EB Cornel, P Zamecnik, IG Schoots, ... European urology 76 (5), 574-581, 2019 | 144 | 2019 |
| Ultra‐small superparamagnetic iron oxides for metastatic lymph node detection: Back on the block AS Fortuin, R Brüggemann, J van der Linden, I Panfilov, B Israël, ... Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 10 (1 …, 2018 | 99 | 2018 |
| Multiparametric magnetic resonance imaging for the detection of clinically significant prostate cancer: what urologists need to know. Part 1: acquisition RRM Engels, B Israël, AR Padhani, JO Barentsz European urology 77 (4), 457-468, 2020 | 88 | 2020 |
| Multiparametric magnetic resonance imaging for the detection of clinically significant prostate cancer: what urologists need to know. Part 2: interpretation B Israël, M van der Leest, M Sedelaar, AR Padhani, P Zamecnik, ... European urology 77 (4), 469-480, 2020 | 65 | 2020 |
| Clinical use of the SelectMDx urinary-biomarker test with or without mpMRI in prostate cancer diagnosis: a prospective, multicenter study in biopsy-naïve men RJ Hendriks, MMG van der Leest, B Israël, G Hannink, A YantiSetiasti, ... Prostate cancer and prostatic diseases 24 (4), 1110-1119, 2021 | 45 | 2021 |
| Evaluating F-18-PSMA-1007-PET in primary prostate cancer and comparing it to multi-parametric MRI and histopathology BM Prive, B Israël, MGM Schilham, CHJ Muselaers, P Zamecnik, ... Prostate cancer and prostatic diseases 24 (2), 423-430, 2021 | 43 | 2021 |
| Focus on the quality of prostate multiparametric magnetic resonance imaging: synopsis of the ESUR/ESUI recommendations on quality assessment and interpretation of images and … M de Rooij, B Israël, T Barrett, F Giganti, AR Padhani, V Panebianco, ... European Urology 78 (4), 483-485, 2020 | 33 | 2020 |
| Head-to-head comparison of 68Ga-prostate-specific membrane antigen PET/CT and ferumoxtran-10–enhanced MRI for the diagnosis of lymph node metastases in prostate cancer patients MGM Schilham, P Zamecnik, BM Privé, B Israël, M Rijpkema, T Scheenen, ... Journal of Nuclear Medicine 62 (9), 1258-1263, 2021 | 27 | 2021 |
| Multiparametric magnetic resonance imaging for the detection of clinically significant prostate cancer: what urologists need to know. Part 4: transperineal magnetic resonance … J Immerzeel, B Israël, J Bomers, IG Schoots, JP Van Basten, KH Kurth, ... European Urology 81 (1), 110-117, 2022 | 24 | 2022 |
| External validation of the Memorial Sloan Kettering Cancer Centre and Briganti nomograms for the prediction of lymph node involvement of prostate cancer using clinical stage … TFW Soeterik, TA Hueting, B Israel, HHE van Melick, LM Dijksman, ... BJU international 128 (2), 236-243, 2021 | 13 | 2021 |
| Ferumoxtran-10-enhanced 3-T magnetic resonance angiography of pelvic arteries: Initial experience P Zamecnik, B Israel, J Feuerstein, J Nagarajah, M Gotthardt, JO Barentsz, ... European Urology Focus 8 (6), 1802-1808, 2022 | 7 | 2022 |
| Can biparametric prostate magnetic resonance imaging fulfill its PROMIS M de Rooij, B Israel, JGR Bomers, IG Schoots, JO Barentsz Eur. Urol 78 (4), 512-514, 2020 | 7 | 2020 |
| Clinical implementation of pre‐biopsy magnetic resonance imaging pathways for the diagnosis of prostate cancer B Israël, J Immerzeel, M van der Leest, G Hannink, P Zámecnik, J Bomers, ... BJU international 129 (4), 480-490, 2022 | 5 | 2022 |
| Reply to Arnaldo Stanzione, Massimo Imbriaco, and Renato Cuocolo's Letter to the Editor re: Marloes van der Leest, Bas Israël, Eric Bastiaan Cornel, et al. High Diagnostic … M van der Leest, B Israël, RRM Engels, JO Barentsz European urology 77 (3), e58-e59, 2020 | 5* | 2020 |
| Global variation in magnetic resonance imaging quality of the prostate F Giganti, A Ng, A Asif, VWS Chan, M Rossiter, A Nathan, P Khetrapal, ... Radiology 309 (1), e231130, 2023 | 3 | 2023 |
| External validation of the MSKCC and Briganti nomograms for prediction of lymph node involvement of prostate cancer using clinical stage assessed by magnetic resonance imaging TFW Soeterik, TA Hueting, B Israel, HHE van Melick, LM Dijksman, ... BJU Int 10, 2021 | 3 | 2021 |
| Implications of the European association of urology recommended risk assessment algorithm for early prostate cancer detection B Israël, G Hannink, JO Barentsz, MMG van der Leest European Urology Open Science 43, 1-4, 2022 | 2 | 2022 |
| Validation of in vivo nodal assessment of solid malignancies with USPIO-enhanced MRI: a workflow protocol DAJJ Driessen, DJJM de Gouw, RCH Stijns, G Litjens, B Israël, ... Methods and Protocols 5 (2), 24, 2022 | 2 | 2022 |
Jelle BarentszProfessor of Radiology, Chairman Radboud Prostate MRI Expert CenterVerified email at radboudumc.nl
